Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aspira Women's Health Inc. (AWHL) vs ProPhase Labs, Inc. (PRPH)

Aspira Women's Health Inc. and ProPhase Labs, Inc. are both Diagnostics & Research companies. Aspira Women's Health Inc. is the larger, with a market value of $2.4M against $1.2M — 2.1× the size. Aspira Women's Health Inc. grew revenue faster over the last twelve months: −8.00% against −43.5%. Aspira Women's Health Inc. has the higher net margin (−117.1% vs −717.4%) and the higher return on invested capital (0.00% vs −387.3%). Across the 17 metrics below, Aspira Women's Health Inc. leads on 12 and ProPhase Labs, Inc. on 5.

Valuation

Metric AWHL PRPH Diagnostics & Research median
P/E n/m n/m 33.95
P/S 1.35 0.04 4.87
P/B n/m n/m 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 1.52 1.84 5.66
Earnings yield (93.85%) (23,896.00%) (1.75%)
Free cash flow yield (41.10%) (3,945.49%) (0.13%)

Profitability

Metric AWHL PRPH Diagnostics & Research median
Gross margin 58.78% 16.38% 50.89%
Operating margin (80.75%) (498.73%) (8.57%)
Net margin (117.07%) (717.43%) (6.37%)
Free cash flow margin (55.32%) (175.22%) 0.00%
Return on equity 201.29% (543.95%) (2.92%)
Return on assets (213.58%) (45.53%) (6.71%)
Return on invested capital 0.00% (387.30%) 0.00%

Growth

Metric AWHL PRPH Diagnostics & Research median
Revenue growth (TTM) (8.00%) (43.52%) 7.69%
EPS growth (last fiscal year) 60.22% 93.33% —
Revenue growth, 5-year CAGR 14.66% (21.43%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AWHL PRPH Diagnostics & Research median
Debt to equity (0.27) (1.82) 0.11
Current ratio 0.52 0.05 2.02
Net debt to EBITDA 0.00 (0.74) 0.78

Dividend

Metric AWHL PRPH Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AWHL PRPH Diagnostics & Research median
Market cap 2.44m 1.17m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack